Request a Quote

Category: Specimen Spotlight

iSpecimen CEO Chris Ianelli

Expect more medical miracles in 2020 and beyond

January 21, 2020

Although January is just another month and the 2020s are just another decade, big changes in the calendar give us pause. As another year unfolds, I marvel at how far biomedical research has come and where it will take us in the next year and beyond.

Read More

Eight Questions with Benjamin Bielak

October 10, 2019

Veteran health care informatics expert Benjamin Bielak recently joined iSpecimen as its first Chief Information Officer. He is the subject of our latest Q&A… The iSpecimen Marketplace is often compared to eBay or Amazon for clarity, but it’s certainly more complicated than that. What are the biggest technology challenges of an online marketplace not for […]

Read More

Specimen Insight Podcast

Specimen Insight podcast: Fast-Tracking Liquid Biopsy Development

September 12, 2019

Liquid biopsies are among the most exciting areas of medical diagnostics. Although the technology is in its early stages, the hope is that liquid biopsies – through a simple draw of blood or other human biofluids – will detect cancer earlier and without the invasiveness of surgical or needle biopsies. The procedure could one day be simple and cost-effective enough to conduct in the doctor’s office or in the comfort of one’s own home, even before symptoms arise.

Read More

Eric Langlois, Senior VP of Business Development

Five questions with Eric Langlois

September 5, 2019

Eric is iSpecimen’s senior vice president of sales and business development. Learn more about him as he answers 5 questions!

Read More

Wayne Vaz head shot

Five questions with Wayne Vaz

August 22, 2019

Wayne joined iSpecimen in June as Vice President of Growth and Corporate Development. He drives go-to-market strategies, key partnerships, and other initiatives that grow the iSpecimen Marketplace.

Read More

petri dish of cell culture

Specimen Spotlight: ‘Matched Sets’ of Biospecimens Give Researchers Deep Insights

August 15, 2019

A disease is an abnormal condition, and to fully understand it, you need to compare abnormal biology against the normal. That’s the concept behind the matched sets of human biospecimens that we provide to researchers around the world.

Read More

Five Questions with Healthcare Data Expert Dave John

July 18, 2019

Dave John joined iSpecimen last month as vice president of product management. Dave is a life sciences data and informatics expert with extensive experience developing solutions for genomics, translational medicine, clinical trials and electronic health records. He will help shape future capabilities of the iSpecimen Marketplace. 1. You are a data expert. How does data […]

Read More

Five Questions with Jill Mullan

June 6, 2019

Learn more about our Chief Operating Officer, Jill Mullan.

Read More

‘iSpecimen Marketplace: Where Discovery Meets Efficiency’ Slide

iSpecimen and you, collaborating to improve biospecimen access for all

March 28, 2019

Since 2014, we at iSpecimen have been committed to helping drive medical breakthroughs by connecting researchers with the human biospecimens they need from the patients who have them. In addition to streamlining researchers’ work, this work has helped biobanks and healthcare organizations fulfill their missions (and generate new revenue) by putting their banked, remnant and prospectively collected specimens to work.

Read More

Beakers and labware

Archived FFPE Tissue Blocks: A Remarkable Value for Many Researchers

November 29, 2018

November Specimen Spotlight Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, […]

Read More

Previous   |